Built for founder-operators of Medicare-certified hospice agencies — this checklist walks you through every financial, clinical, and compliance step needed to attract qualified buyers and close at 4–7x EBITDA.
Selling an independent hospice or palliative care agency is one of the most complex transactions in the lower middle market. Buyers — whether regional hospice roll-up platforms backed by private equity, large national hospice chains, or SBA-financed owner-operators — will conduct exhaustive due diligence on your Medicare reimbursement history, clinical compliance record, referral source relationships, and staff stability. A single unresolved RAC audit finding, a referral source that accounts for 40% of your census, or three years of commingled financials can kill a deal or cut your valuation by six figures. The good news: most of these issues are fixable with 12–24 months of preparation. This checklist gives you a phased roadmap to clean up your books, document your clinical operations, protect your referral relationships, and present your hospice business in the strongest possible light to the buyers who matter most.
Get Your Free Hospice & Palliative Care Exit ScorePrepare 3 years of accrual-based financial statements
Work with a healthcare-experienced CPA to recast your income statements using accrual-basis accounting for all three prior fiscal years. Hospice agencies frequently book revenue on a cash basis, which distorts margin presentation and raises red flags with sophisticated buyers and their lenders. Accrual-based statements that align with Medicare cost report periods are the standard buyers expect.
Normalize EBITDA by removing owner-specific expenses
Identify and document all personal expenses run through the business — owner vehicle, personal health insurance, above-market owner salary, family member payroll, and any related-party real estate leases. Present a clearly sourced EBITDA bridge that shows adjusted earnings. Buyers will do this anyway; doing it first signals transparency and accelerates trust.
Calculate and document your Medicare cap position
Pull your Medicare hospice cap calculations for the last three benefit periods and project your exposure for the next 12 months. Buyers will request this on day one of due diligence. An agency approaching 90–95% of its annual cap limit is a serious valuation risk. Document your aggregate cap calculation methodology and have your billing team prepare a written summary.
Reconcile Medicare cost reports and identify any overpayment exposure
Review filed Medicare cost reports for the last three years and confirm there are no outstanding settlement liabilities, open cost report years, or unresolved overpayment demands from your Medicare Administrative Contractor. Any open items should be disclosed proactively with a written summary of status and projected resolution.
Separate personal and business banking and credit accounts
If you have commingled personal and business finances — common in sole-proprietor or single-member LLC hospice operations — open dedicated business accounts and begin routing all revenue and expenses through clean business accounts. Buyers and SBA lenders will require 24 months of business bank statements that reconcile cleanly to your P&L.
Compile all Medicare and Medicaid certification documents and survey history
Assemble your current Medicare provider agreement, CMS Certification Number, state licensure certificates, and the last three years of state and federal survey reports including any Plans of Correction. Buyers will scrutinize every deficiency citation. Condition-level deficiencies or repeat standard-level citations are major red flags. If you have open POCs, resolve and document them now.
Organize QAPI documentation, IDT meeting records, and clinical process files
Buyers conducting clinical due diligence will request QAPI meeting minutes, interdisciplinary team documentation, care plan audit results, and clinical outcome data including live discharge rates and length-of-stay averages. These records demonstrate operational discipline and reduce the perception of post-acquisition integration risk.
Audit employee licensure files and confirm all clinical staff credentialing is current
Verify that every RN, LPN, social worker, chaplain, and home health aide has a current, active license in your state and that your credentialing files contain primary-source verification documentation. Buyers will sample these files during due diligence. Expired licenses or missing credentials in personnel files create liability exposure and delay closings.
Review and document anti-kickback statute compliance for all referral relationships
Audit your arrangements with referral sources — hospitals, SNFs, physician groups, and assisted living facilities — for AKS safe harbor compliance. Ensure no gifts, meals, marketing payments, or below-market services are being provided to referral sources outside of established safe harbors. Document all written agreements with referral partners and confirm they reflect fair market value.
Obtain or renew ACHC or CHAP accreditation if not currently held
Accreditation from ACHC or CHAP is increasingly expected by institutional buyers as a signal of quality infrastructure. If you are not currently accredited, begin the application process now. If you are accredited, confirm your certificate is current and note the next survey date. Accreditation can also substitute for state surveys in many jurisdictions, reducing ongoing regulatory burden.
Prepare a 24-month ADC trend report with payer mix and diagnosis breakdowns
Build a month-by-month average daily census report for the last two years segmented by payer — Medicare, Medicaid, and private insurance — and by primary diagnosis category. Buyers will use ADC trajectory to project revenue, assess growth potential, and stress-test their acquisition model. A stable or growing ADC with Medicare as the dominant payer is the profile buyers want to see.
Document live discharge rates and length-of-stay data with benchmarks
Calculate your live discharge rate as a percentage of total discharges for the last 24 months and compare it against the national average. High live discharge rates are an OIG scrutiny trigger and a clinical compliance red flag. Document your eligibility certification process and show how your rates compare to CMS benchmarks. Length-of-stay data showing appropriate median LOS strengthens your clinical story.
Map your referral source network with volume and concentration data
Build a referral source report showing total admissions by source for the last 24 months. Identify the percentage of admissions from your top five referral sources. No single source should exceed 20% of admissions. If you have concentration risk, begin actively diversifying your referral development activities now. Document any written referral agreements and confirm they are compliant.
Document your EMR system, billing workflows, and operational processes
Prepare a written overview of your EMR platform — whether Netsmart, Brightree, Homecare Homebase, or another system — including user counts, license terms, and data export capabilities. Document your billing cycle, claims submission process, and denial management workflow. Buyers want to know that revenue cycle operations can survive a change of ownership without disruption.
Assess your geographic service area and expansion opportunity
Prepare a summary of your current licensed service area, counties served, and any unfilled capacity within your geographic footprint. Buyers — particularly PE-backed roll-up platforms — pay premiums for agencies in under-penetrated markets or those with existing relationships that could support census growth. Map your nearest competitor locations and identify your defensible referral territory.
Secure retention commitments from your Director of Nursing and Administrator
Your Director of Nursing and Administrator are the two roles that buyers consider non-negotiable for business continuity. Have direct conversations with these individuals about the potential sale. Gauge their willingness to stay through and beyond the transition. Consider retention bonus agreements tied to employment through the closing date and 6–12 months post-close. Document their licensure, tenure, and clinical credentials in a leadership summary.
Identify and approach qualified buyers or engage a sell-side M&A advisor
Not all buyers understand hospice operations, Medicare CHOW requirements, or the clinical nuances of end-of-life care. Work with a sell-side advisor or broker who has completed hospice transactions in the lower middle market and has relationships with regional roll-up operators, strategic acquirers, and SBA-qualified buyer candidates. A competitive process with two to four qualified buyers will maximize your outcome.
Engage a healthcare M&A attorney experienced in Medicare CHOW
The Medicare Change of Ownership process requires specific notification timelines, provider agreement novation steps, and coordination with your Medicare Administrative Contractor. A healthcare transactional attorney who has navigated CMS CHOW requirements will protect you from procedural errors that could delay closing or create post-sale liability. Do not use a generalist business attorney for this transaction.
Prepare a confidential information memorandum summarizing your business
Work with your advisor to prepare a professional CIM that presents your hospice agency's financial performance, clinical quality metrics, ADC trends, referral network, team, compliance history, and growth opportunity. This document is the first impression for qualified buyers and sets the tone for the entire process. A poorly prepared or incomplete CIM signals operational weakness before a single diligence question is asked.
Understand your deal structure options and tax implications before going to market
Consult with your CPA and M&A attorney on the tax treatment of an asset sale versus a stock sale, the implications of Medicare provider agreement novation, and how seller notes or earnouts tied to census retention will affect your net proceeds. Most hospice deals are structured as asset purchases with some form of earnout or seller note. Understanding this before you receive a LOI prevents late-stage surprises.
See What Your Hospice & Palliative Care Business Is Worth
Free exit score, valuation range, and personalized action plan — 5 minutes.
Medicare-certified hospice agencies in the lower middle market typically sell for 4–7x adjusted EBITDA. A well-run agency with $500K in normalized EBITDA, a clean compliance history, a growing ADC, and a diversified referral network can command the upper end of that range. Agencies with Medicare cap exposure, referral concentration risk, or thin clinical staffing typically trade at 4–5x or require earnout structures that reduce effective day-one proceeds. Revenue of $1M–$5M and EBITDA of $300K–$1.5M represents the core acquisition target range for most active hospice buyers.
The Medicare CHOW process adds meaningful complexity and time to any hospice transaction. CMS requires the seller to notify the Medicare Administrative Contractor in advance of the ownership change, and the buyer must submit a new enrollment application — including a new CMS-855A — before they can bill Medicare under the existing provider agreement. Depending on whether the deal is structured as an asset purchase or stock purchase, the CHOW process can take 60–120 days post-closing and requires careful coordination between your healthcare attorney, the buyer's counsel, and your MAC. Asset purchases require a full provider agreement novation, while stock purchases allow the buyer to retain the existing certification — which is one reason some buyers prefer stock deals despite the associated liability exposure.
Yes — always. Sophisticated hospice buyers and their diligence teams will request your complete RAC audit history, any overpayment demands from your MAC, OIG exclusion database checks on all key staff, and cost report settlement status. Any issues that are disclosed proactively and resolved are manageable. Issues discovered mid-diligence — particularly undisclosed overpayment demands or active OIG investigations — are deal-killers that will either collapse the transaction or result in dollar-for-dollar escrow holdbacks and significant purchase price reductions. Full transparency with your advisor before going to market is the only viable strategy.
You can sell, but buyer-perceived risk and deal structure will reflect this heavily. If your census is significantly dependent on relationships you personally hold with hospital discharge planners, physicians, or SNF administrators, buyers will structure earnouts tied to census retention post-close, require your personal involvement during a longer transition period, or reduce the upfront purchase price to reflect the risk that census declines after your departure. The best mitigation is to spend 12–18 months before going to market actively transferring referral relationships to your clinical team, Administrator, or dedicated business development staff so that the relationships belong to the agency rather than to you personally.
In an asset sale — the most common structure in hospice transactions — the buyer acquires specific assets of the business including the Medicare provider agreement through a CHOW novation, client census, clinical records, equipment, and contracts, while leaving most liabilities with the seller. This structure requires a full Medicare CHOW process but gives the buyer a clean liability start. In a stock sale, the buyer acquires the legal entity itself, including all historical liabilities — billing compliance risk, open cost report years, and any undisclosed regulatory exposure. Buyers sometimes prefer stock purchases to retain the existing Medicare certification without a full novation, but they will demand deeper due diligence and larger escrow holdbacks to protect against inherited compliance risk. Most sellers prefer asset sales for the liability protection they provide.
From the decision to sell through closing, most hospice agency transactions in the lower middle market take 12–24 months when you include preparation time. If your financials are already clean, your compliance record is solid, and you have an advisor ready to run a process, you might reach closing in 9–12 months. But if you need to recast three years of financial statements, resolve Medicare cap issues, diversify referral sources, or address survey deficiencies, budget 18–24 months from decision to closing. Rushing the process without adequate preparation typically results in a lower valuation, more aggressive deal structure terms, and greater post-closing liability exposure.
No — and you should be very careful about premature disclosure. Telling clinical staff about a potential sale before you have a signed LOI and high confidence of closing is one of the most common mistakes hospice sellers make. It triggers staff anxiety, voluntary departures, and referral source uncertainty that can directly damage your ADC and the business value you are trying to maximize. Work confidentially with your advisor and attorney throughout the process. Most buyers expect to be involved in a structured staff communication plan as part of closing logistics — your advisor can help you design a disclosure timeline that protects census and staff morale during the transition.
More Hospice & Palliative Care Seller Guides
More Exit Checklists
Get your Hospice & Palliative Care exit score, estimated valuation, and a step-by-step action plan — free, in 5 minutes.
Start Your Free Exit AssessmentFree forever · No broker needed · Takes 5 minutes
For Buyers
For Sellers